Compare NRC & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRC | FINS |
|---|---|---|
| Founded | 1981 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.8M | 436.4M |
| IPO Year | 1997 | 2018 |
| Metric | NRC | FINS |
|---|---|---|
| Price | $17.48 | $12.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 68.9K | 45.4K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.76% | N/A |
| EPS Growth | ★ 4707.69 | N/A |
| EPS | ★ 50.00 | N/A |
| Revenue | ★ $119,686,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.34 | ★ N/A |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $9.76 | $12.38 |
| 52 Week High | $22.79 | $13.55 |
| Indicator | NRC | FINS |
|---|---|---|
| Relative Strength Index (RSI) | 59.62 | 57.23 |
| Support Level | $16.64 | $12.88 |
| Resistance Level | $18.18 | $13.26 |
| Average True Range (ATR) | 0.73 | 0.15 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 82.99 | 83.35 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.